Transcatheter aortic valve replacement (TAVR) has begun to replace surgical AVR (SAVR) as the predominant modality for valve replacement in patients with severe aortic stenosis (AS). However, stroke remains a significant TAVR complication, with 30-day post-TAVR ischemic stroke rates of up to 6.7% reported in the pivotal TAVR device trials. Few risk factors for peri-TAVR stroke have been identified. A meta-analysis of 64 studies including 72,318 patients with 2385 (3.3%) strokes identified female sex, chronic kidney disease, new-onset atrial fibrillation, and early timing in a center's TAVR experience as stroke predictors, none of which are modifiable.